Does FLUVASTATIN Cause Interstitial lung disease? 34 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Interstitial lung disease have been filed in association with FLUVASTATIN (FLUVASTATIN SODIUM ER). This represents 1.9% of all adverse event reports for FLUVASTATIN.
34
Reports of Interstitial lung disease with FLUVASTATIN
1.9%
of all FLUVASTATIN reports
2
Deaths
27
Hospitalizations
How Dangerous Is Interstitial lung disease From FLUVASTATIN?
Of the 34 reports, 2 (5.9%) resulted in death, 27 (79.4%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for FLUVASTATIN.
What Other Side Effects Does FLUVASTATIN Cause?
Myalgia (577)
Dizziness (304)
Arthralgia (263)
Diarrhoea (260)
Headache (260)
Pruritus (257)
Dyspnoea (234)
Fall (234)
Insomnia (234)
Fatigue (231)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which FLUVASTATIN Alternatives Have Lower Interstitial lung disease Risk?
FLUVASTATIN vs FLUVOXAMINE
FLUVASTATIN vs FOLATE
FLUVASTATIN vs FOLIC ACID
FLUVASTATIN vs FOLINIC ACID
FLUVASTATIN vs FOLLICLE STIMULATING HORMONE BETA POLYPEPTIDE\LUTROPIN ALFA